KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $6.3 billion.

  • Idexx Laboratories' Treasury Shares rose 2426.89% to $6.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 billion, marking a year-over-year increase of 2426.89%. This contributed to the annual value of $5.3 billion for FY2024, which is 1920.43% up from last year.
  • Per Idexx Laboratories' latest filing, its Treasury Shares stood at $2.1 million for Q3 2025, which was down 9193.19% from $27.9 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Treasury Shares registered a high of $27.9 million during Q2 2025, and its lowest value of $19000.0 during Q2 2023.
  • Moreover, its 5-year median value for Treasury Shares was $22.8 million (2022), whereas its average is $14.7 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 3229.98% in 2022, then surged by 187.99% in 2023.
  • Idexx Laboratories' Treasury Shares (Quarter) stood at $3.6 billion in 2021, then rose by 23.0% to $4.4 billion in 2022, then grew by 1.88% to $4.5 billion in 2023, then rose by 19.2% to $5.3 billion in 2024, then grew by 18.47% to $6.3 billion in 2025.
  • Its last three reported values are $6.3 billion in Q3 2025, $6.1 billion for Q2 2025, and $5.7 billion during Q1 2025.